ScreenerHero

VREOVireo Growth Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · vireogrowth.com
16.37CAD+9.06%Mkt Cap: 615.01M $P/E: —

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells ca…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$62.66BUSDP/E 24.3
TAK
Takeda Pharmaceutical Company Limited
$60.33BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.72BUSDP/E 66.8
HLN
Haleon plc
$41.16BUSDP/E 19.5
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.6
ZOE
Zoetis Inc.
$27.77BUSDP/E 11.6
UTHR
United Therapeutics Corporation
$21.22BUSDP/E 17.7
VTRS
Viatris, Inc.
$19.47BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.80BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.63BUSDP/E 21.0
IPN
Ipsen S.A.
$13.27BUSDP/E 24.0
ELAN
Elanco Animal Health Incorporated
$11.20BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.33BUSDP/E 30.2
KRK
Krka, d. d.
$8.66BUSDP/E 18.8
ALKS
Alkermes plc
$7.41BUSDP/E 116.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.02BUSDP/E 42.0
HIMS
Hims & Hers Health, Inc.
$6.85BUSD
LNTH
Lantheus Holdings, Inc.
$6.55BUSDP/E 24.0
KNSA
Kiniksa Pharmaceuticals International, plc
$6.10BUSDP/E 78.9
LQDA
Liquidia Corporation
$5.95BUSDP/E 47.5

Key Statistics

Company
Market Cap615.01M $
Enterprise Value846.85M $
Revenue (TTM)372.63M $
Gross Profit92.56M $
Net Income (TTM)-49.60M $
Revenue/Share10.06 USD
Last Price16.37 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees520
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA19.11
EV/Revenue2.27
P/S1.61
P/B1.20
EPS (TTM)-2.55
EPS (Forward)—
52W Range
12.5720% of range31.50
52W High31.50 CAD
52W Low12.57 CAD
Profitability
Gross Margin47.29%
Oper. Margin6.40%
EBITDA Margin11.89%
Profit Margin-25.34%
ROE-22.16%
ROA-8.34%
Growth
Revenue Growth335.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.70M $
CapEx (TTM)21.71M $
FCF Margin-8.39%
FCF Yield-5.09%
Net Debt277.98M $
Net Debt/EBITDA6.27
Balance Sheet
Debt/Equity0.99
Current Ratio1.01
Quick Ratio0.48
Book Value/Sh13.33 CAD
Cash/Share2.132 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJun 5, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.50.82M
Float31.11M
Insiders31.39%
Institutions7.39%
Short Interest
Short Ratio0.1d
Short % Float0.00%
Short % Out.0.00%
Shares Short794
Short (prev mo.)601
Technical
SMA 5014.86 (+10.2%)
SMA 20017.94 (-8.8%)
Beta0.10
S&P 52W Chg14.29%
Avg Vol (30d)10.16K
Avg Vol (10d)16.43K
Technical Indicators
RSI (14)56.7
MACD0.2280
MACD Signal0.0898
MACD Hist.+0.1382
BB Upper15.94 CAD
BB Middle14.36 CAD
BB Lower12.78 CAD
BB Width22.04%
ATR (14)0.4389 CAD
Vol Ratio (20d)0.88x